Arax Advisory Partners’s AtriCure ATRC Stock Holding History

Arax Advisory Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Buy	4,388 +4,339	+8,855%	+$122K	﹤0.01%	2586
2026 Q1	$1.4K	Buy	49 +31	+172%	+$1.06K	﹤0.01%	3210
2025 Q4	$713	Sell	18 -127	-88%	-$4.66K	﹤0.01%	3547
2025 Q3	$5.11K	Buy	145 +127	+706%	+$4.38K	﹤0.01%	2866
2025 Q2	$591	Sell	18 -70	-80%	-$2.27K	﹤0.01%	2908
2025 Q1	$2.84K	Buy	88 +16	+22%	+$594	﹤0.01%	1969
2024 Q4	$2.2K	Buy	72 +42	+140%	+$1.35K	﹤0.01%	1991
2024 Q3	$842	Sell	30 -8	-21%	-$197	﹤0.01%	2310
2024 Q2	$866	Buy	38 +34	+850%	+$785	﹤0.01%	2211
2024 Q1	$122	Hold	4	–	–	﹤0.01%	1285
2023 Q4	$143	Sell	4 -19	-83%	-$707	﹤0.01%	1296
2023 Q3	$1.01K	Hold	23	–	–	﹤0.01%	1125
2023 Q2	$1.14K	Hold	23	–	–	﹤0.01%	1091
2023 Q1	$954	Hold	23	–	–	﹤0.01%	1110
2022 Q4	$1.02K	Hold	23	–	–	﹤0.01%	1068
2022 Q3	$1K	Buy	23 +4	+21%	+$183	﹤0.01%	1031
2022 Q2	$1K	Hold	19	–	–	﹤0.01%	1005
2022 Q1	$1K	Hold	19	–	–	﹤0.01%	993
2021 Q4	$1K	Buy	+19	New	+$1.38K	﹤0.01%	968

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arax Advisory Partners's ATRC Position: Q2 2026 in Review

Arax Advisory Partners increased its AtriCure (ATRC) stake by 8,855% in Q2 2026, buying an estimated $122K and bringing the position to 4,388 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

Arax Advisory Partners first reported a position in ATRC in Q4 2021 and has held it in 19 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Arax Advisory Partners held 4,388 shares of AtriCure worth $123K as of Q2 2026.
Arax Advisory Partners bought 4,339 AtriCure shares in Q2 2026, an estimated $122K.
AtriCure made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2586 holding.
Arax Advisory Partners first reported a position in AtriCure in Q4 2021 and has held it in 19 quarters since.
252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.